{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal UMC119-06-05",
            "NStudiesAvail": 430108,
            "NStudiesFound": 2,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 2,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "The clinical study with UMC119-06-05 is designed to investigate the safety in patients with frailty syndrome. This will be a dose escalation, open label, single-center study in adult with frailty syndrome. UMC119-06-05 is ex vivo cultured human umbilical cord tissue-derived mesenchymal stem cells product which is intended for treatment of frailty syndrome."
                        ],
                        "BriefTitle": [
                              "Mesenchymal Stem Cells for The Treatment of Frailty Syndrome"
                        ],
                        "CentralContactEMail": [
                              "Mandy.Li@meridigen.com",
                              "Katherine.Huang@meridigen.com"
                        ],
                        "CentralContactName": [
                              "Mandy Li, MS",
                              "Katherine Huang, MS"
                        ],
                        "CentralContactPhone": [
                              "+886-2-2627-5175",
                              "+886-2-2627-5175"
                        ],
                        "CentralContactPhoneExt": [
                              "19933",
                              "19926"
                        ],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Frailty Syndrome"
                        ],
                        "ConditionAncestorId": [
                              "D000004194",
                              "D000010335"
                        ],
                        "ConditionAncestorTerm": [
                              "Disease",
                              "Pathologic Processes"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All"
                        ],
                        "NCTId": [
                              "NCT04914403"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "The clinical study with UMC119-06-05 is designed to investigate the safety in patients with mild to moderate knee osteoarthritis (KOA). This will be a dose escalation, open label, single-center study in adult with mild to moderate knee osteoarthritis. UMC119-06-05 is ex vivo cultured human umbilical cord tissue-derived mesenchymal stem cells product which is intended for treatment of knee osteoarthritis."
                        ],
                        "BriefTitle": [
                              "Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA)."
                        ],
                        "CentralContactEMail": [
                              "julie.wen@meridigen.com",
                              "Katherine.Huang@meridigen.com"
                        ],
                        "CentralContactName": [
                              "Julie Wen, MS",
                              "Katherine Huang, MS"
                        ],
                        "CentralContactPhone": [
                              "+886-2-2627-5175",
                              "+886-2-2627-5175"
                        ],
                        "CentralContactPhoneExt": [
                              "19922",
                              "19926"
                        ],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Osteoarthritis, Knee"
                        ],
                        "ConditionAncestorId": [
                              "D000001168",
                              "D000007592",
                              "D000009140",
                              "D000012216"
                        ],
                        "ConditionAncestorTerm": [
                              "Arthritis",
                              "Joint Diseases",
                              "Musculoskeletal Diseases",
                              "Rheumatic Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "All",
                              "BC17"
                        ],
                        "NCTId": [
                              "NCT04893174"
                        ]
                  }
            ]
      }
}